Cargando…
Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer
To understand the mechanism underlying metastasis, identification of a mechanism-based and common biomarker for circulating tumour cells (CTCs) in heterogenous breast cancer is needed. SET, an endogenous inhibitor of protein phosphatase 2A, was overexpressed in all subtypes of invasive breast carcin...
Autores principales: | Tozuka, Katsunori, Wongsirisin, Pattama, Nagai, Shigenori E., Kobayashi, Yasuhito, Kanno, Miki, Kubo, Kazuyuki, Takai, Ken, Inoue, Kenichi, Matsumoto, Hiroshi, Shimizu, Yoshihito, Suganuma, Masami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270961/ https://www.ncbi.nlm.nih.gov/pubmed/34244560 http://dx.doi.org/10.1038/s41598-021-93620-y |
Ejemplares similares
-
Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
por: Rawangkan, Anchalee, et al.
Publicado: (2018) -
(−)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells
por: Namiki, Kozue, et al.
Publicado: (2020) -
Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
por: Kurozumi, Sasagu, et al.
Publicado: (2017) -
Structure‐Function Relationships of Microcystins, Liver Tumor Promoters, in Interaction with Protein Phosphatase
por: Nishiwaki‐Matsushima, Rie, et al.
Publicado: (1991) -
Growth Factor Deregulation and Emerging Role of Phosphatases in Diabetic Peripheral Artery Disease
por: Mercier, Clément, et al.
Publicado: (2021)